Aquaculture Pathophysiology

Aquaculture Pathophysiology

Volume II. Crustacean and Molluscan Diseases

1st Edition - August 25, 2022

Write a review

  • Editors: Frederick S.B. Kibenge, Bernardo Baldisserotto, Roger Sie-Maen Chong
  • Paperback ISBN: 9780323954341

Purchase options

Purchase options
Available
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Aquaculture Pathophysiology, Volume II. Crustacean and Molluscan Diseases is a concise, practical reference on shellfish diseases of significant risk to aquaculture. Its value to the veterinarian, fish health biologist or extensionist, fish pathologist and fish health diagnostician is its easy reach for critical information on the diagnosis and management of significant infectious and non-infectious diseases for the major temperate, subtropical and tropical shellfish species of commercial and fisheries importance. This volume should be read in partnership with volume one on finfish diseases as the principles and approach to the diagnosis and management of aquacultured animal species are similar. This comprehensive resource is ideal for researchers, teachers, students, diagnostic laboratory scientists, aquaculture technicians, and farmers who need to be competent across both finfish and shellfish health issues.

Key Features

  • Presents a focus on the disease process of major or emerging viral, bacterial, fungal and parasitic infections affecting aquacultured shellfish species e.g., shrimp, lobsters, crayfish, crabs, oysters, mussels, abalone and scallops
  • Focuses on important or emerging environmental, nutritional, genetic, deformity, toxicological, endocrine disruption, and neoplastic diseases in crustaceans and mollusks
  • Provides a review of the immunology of shellfish relevant to a practical understanding of disease diagnosis and management
  • Includes an overview of laboratory diagnostic methods relevant to the detection of shellfish diseases
  • Discusses the diverse risk factors of shellfish diseases and options for their control

Readership

Researchers, teachers, students, diagnostic laboratory staff, clinical veterinarians, aquaculture disease practitioners, biologists, farmers, and all those in industry, government or academia who are interested in aquaculture, fisheries and comparative biology

Table of Contents

  • Cover image
  • Title page
  • Table of Contents
  • Copyright
  • Contributors
  • About the editors
  • Preface
  • Section I. Crustacean diseases
  • Chapter 1. Crustacean disease laboratory methods
  • 1.1. Overview
  • 1.2. Necropsy
  • 1.3. Sampling for serology and gene probe assays
  • 1.4. Histology
  • 1.5. Gene probe and in-situ hybridization assays
  • 1.6. ELISA assay
  • 1.7. Molecular diagnostics
  • 1.8. Electron microscopy
  • 1.9. Assays for specific diseases
  • Chapter 2. Crustacean diseases terminology
  • 2.1. Overview
  • Chapter 3. Crustacean immunology
  • 3.1. Overview
  • 3.2. Cell-mediated immunity
  • 3.3. Hemolymph factors
  • 3.4. Immune tissues
  • 3.5. Pathogen recognition
  • 3.6. Enzyme cascades
  • 3.7. Signaling pathways
  • 3.8. Apoptosis
  • 3.9. Immune stimulation
  • 3.10. Vaccination or immune priming
  • 3.11. RNA interference
  • 3.12. Immune-related genes and its functions
  • 3.13. Immunostimulants in the crustacean immune system
  • 3.14. Immune protein and nanotechnology
  • 3.15. Research
  • Section II. Viral diseases
  • Chapter 4. Covert mortality disease
  • 4.1. Overview
  • 4.2. Etiological agent
  • 4.3. Clinical signs and gross pathology
  • 4.4. Histopathology
  • 4.5. Disease risk factors
  • 4.6. Pathogen isolation and identification
  • 4.7. Molecular diagnostics
  • 4.8. Disease control
  • Chapter 5. Crab viral diseases
  • 5.1. Overview
  • 5.2. Etiological agents
  • 5.3. Clinical signs and gross pathology
  • 5.4. Histopathology
  • 5.5. Disease risk factors
  • 5.6. Disease control
  • Chapter 6. Crayfish viral diseases
  • 6.1. Overview
  • 6.2. Aetiological agents
  • 6.3. Clinical signs and gross pathology
  • 6.4. Histopathology
  • 6.5. Disease risk factors and disease control
  • Chapter 7. Infectious hypodermal and hematopoietic necrosis virus disease
  • 7.1. Overview
  • 7.2. Etiological agent
  • 7.3. Clinical signs and gross pathology
  • 7.4. Histopathology
  • 7.5. Disease risk factors
  • 7.6. Molecular diagnostics
  • 7.7. Immunodiagnostics
  • 7.8. Disease control
  • Chapter 8. Infectious myonecrosis virus disease
  • 8.1. Overview
  • 8.2. Etiological agent
  • 8.3. Clinical signs and gross pathology
  • 8.4. Histopathology
  • 8.5. Disease risk factors
  • 8.6. Clinical pathology
  • 8.7. Pathogen isolation and identification
  • 8.8. Immunodiagnostics
  • 8.9. Molecular diagnostics
  • 8.10. Disease control
  • Chapter 9. Lobster Panulirus argus virus 1 disease
  • 9.1. Overview
  • 9.2. Etiological agent
  • 9.3. Clinical signs and gross pathology
  • 9.4. Histopathology
  • 9.5. Disease risk factors
  • 9.6. Clinical pathology
  • 9.7. Pathogen isolation and identification
  • 9.8. Molecular diagnostics
  • 9.9. Disease control
  • Chapter 10. Monodon slow growth syndrome
  • 10.1. Overview
  • 10.2. Etiological agent
  • 10.3. Clinical signs and gross pathology
  • 10.4. Histopathology
  • 10.5. Disease risk factors
  • 10.6. Clinical pathology
  • 10.7. Pathogen isolation and identification
  • 10.8. Molecular diagnostics
  • 10.9. Disease control
  • Chapter 11. Spherical baculovirosis
  • 11.1. Overview
  • 11.2. Etiological agent
  • 11.3. Clinical signs and gross pathology
  • 11.4. Histopathology
  • 11.5. Disease risk factors
  • 11.6. Clinical pathology
  • 11.7. Immunodiagnostics
  • 11.8. Molecular diagnostics
  • 11.9. Disease control
  • Chapter 12. Shrimp hemocyte iridescent virus (decapod iridescent virus 1)
  • 12.1. Overview
  • 12.2. Etiological agent
  • 12.3. Clinical signs and gross pathology
  • 12.4. Histopathology
  • 12.5. Disease risk factors
  • 12.6. Pathogen isolation and identification
  • 12.7. Molecular diagnostics
  • 12.8. Disease control
  • Chapter 13. Taura syndrome virus disease
  • 13.1. Overview
  • 13.2. Etiological agent
  • 13.3. Clinical signs and gross pathology
  • 13.4. Histopathology
  • 13.5. Disease risk factors
  • 13.6. Clinical pathology
  • 13.7. Immunodiagnostics
  • 13.8. Pathogen isolation and identification
  • 13.9. Molecular diagnostics
  • 13.10. Disease control
  • Chapter 14. Tetrahedral baculovirosis
  • 14.1. Overview
  • 14.2. Etiological agent
  • 14.3. Clinical signs and gross pathology
  • 14.4. Histopathology
  • 14.5. Disease risk factors
  • 14.6. Immunodiagnostics
  • 14.7. Clinical pathology
  • 14.8. Molecular diagnostics
  • 14.9. Disease control
  • Chapter 15. White spot syndrome virus and disease
  • 15.1. Overview
  • 15.2. Etiological agent
  • 15.3. Clinical signs and gross pathology
  • 15.4. Histopathology
  • 15.5. Disease risk factors
  • 15.6. Clinical pathology
  • 15.7. Pathogen isolation and identification
  • 15.8. Immunodiagnostics
  • 15.9. Molecular diagnostics
  • 15.10. Disease control
  • Chapter 16. White spot syndrome virus in wild mud crabs
  • 16.1. Overview
  • 16.2. Etiological agent
  • 16.3. Clinical signs and gross pathology
  • 16.4. Histopathology
  • 16.5. Clinical pathology
  • 16.6. Disease risk factors
  • 16.7. Pathogen isolation and identification
  • 16.8. Immunodiagnostics
  • 16.9. Molecular diagnostics
  • 16.10. Disease control
  • Chapter 17. White tail disease
  • 17.1. Overview
  • 17.2. Etiological agent
  • 17.3. Clinical signs and gross pathology
  • 17.4. Histopathology
  • 17.5. Clinical pathology
  • 17.6. Disease risk factors
  • 17.7. Pathogen isolation and identification
  • 17.8. Immunodiagnostics
  • 17.9. Molecular diagnostics
  • 17.10. Disease control
  • Chapter 18. Yellow head viruses and disease
  • 18.1. Overview
  • 18.2. Etiological agent
  • 18.3. Clinical signs and gross pathology
  • 18.4. Histopathology
  • 18.5. Immunodiagnostics
  • 18.6. Molecular diagnostics
  • 18.7. Pathogen isolation and identification
  • 18.8. Disease risk factors
  • 18.9. Disease control
  • Section III. Bacterial diseases
  • Chapter 19. Acute hepatopancreatic necrosis disease
  • 19.1. Overview
  • 19.2. Etiological agents
  • 19.3. Clinical signs and gross pathology
  • 19.4. Histopathology
  • 19.5. Disease risk factors
  • 19.6. Clinical pathology
  • 19.7. Pathogen isolation and identification
  • 19.8. Immunodiagnostics
  • 19.9. Molecular diagnostics
  • 19.10. Disease control
  • Chapter 20. Crab larval luminescent vibriosis
  • 20.1. Overview
  • 20.2. Etiological agent
  • 20.3. Clinical signs and gross pathology
  • 20.4. Disease risk factors
  • 20.5. Clinical pathology
  • 20.6. Pathogen isolation and identification
  • 20.7. Disease control
  • Chapter 21. Chitinolytic shell disease
  • 21.1. Overview
  • 21.2. Etiological agents and pathogenesis
  • 21.3. Clinical signs and gross pathology
  • 21.4. Histopathology
  • 21.5. Disease risk factors
  • 21.6. Clinical pathology
  • 21.7. Pathogen isolation and identification
  • 21.8. Disease control
  • Chapter 22. Lobster gaffkemia
  • 22.1. Overview
  • 22.2. Etiological agent
  • 22.3. Clinical signs and gross pathology
  • 22.4. Histopathology
  • 22.5. Disease risk factors
  • 22.6. Clinical pathology
  • 22.7. Pathogen isolation and identification
  • 22.8. Immunodiagnostics
  • 22.9. Molecular diagnostics
  • 22.10. Disease control
  • Chapter 23. Mitten crab tremor disease
  • 23.1. Overview
  • 23.2. Etiological agent
  • 23.3. Clinical signs and gross pathology
  • 23.4. Histopathology
  • 23.5. Disease risk factors
  • 23.6. Clinical pathology
  • 23.7. Pathogen isolation and identification
  • 23.8. Molecular diagnostics
  • 23.9. Immunodiagnostics
  • 23.10. Disease control
  • Chapter 24. Necrotizing hepatopancreatitis
  • 24.1. Overview
  • 24.2. Etiological agent
  • 24.3. Clinical signs and gross pathology
  • 24.4. Histopathology
  • 24.5. Disease risk factors
  • 24.6. Clinical pathology
  • 24.7. Pathogen isolation and identification
  • 24.8. Molecular diagnostics
  • 24.9. Disease control
  • Chapter 25. Shrimp mycobacteriosis
  • 25.1. Overview
  • 25.2. Etiological agent
  • 25.3. Clinical signs and gross pathology
  • 25.4. Histopathology
  • 25.5. Disease risk factors
  • 25.6. Pathogen isolation and identification
  • 25.7. Molecular diagnostics
  • 25.8. Disease control
  • Chapter 26. Shrimp rickettsial disease
  • 26.1. Overview
  • 26.2. Etiological agent
  • 26.3. Clinical signs and gross pathology
  • 26.4. Histopathology
  • 26.5. Disease risk factors
  • 26.6. Clinical pathology
  • 26.7. Pathogen isolation and identification
  • 26.8. Molecular diagnostics
  • 26.9. Disease control
  • Chapter 27. Shrimp Vibriosis
  • 27.1. Overview
  • 27.2. Etiological agent
  • 27.3. Clinical signs and gross pathology
  • 27.4. Histopathology
  • 27.5. Host pathogen interactions
  • 27.6. Disease risk factors
  • 27.7. Pathogen isolation and identification
  • 27.8. Disease control and prevention
  • Section IV. Parasitic diseases
  • Chapter 28. Bitter crab disease
  • 28.1. Overview
  • 28.2. Etiological agent
  • 28.3. Clinical signs and gross pathology
  • 28.4. Histopathology
  • 28.5. Disease risk factors
  • 28.6. Clinical pathology
  • 28.7. Pathogen culture and identification
  • 28.8. Molecular diagnostics
  • 28.9. Disease control
  • Chapter 29. Crab ciliate disease
  • 29.1. Overview
  • 29.2. Etiological agents
  • 29.3. Clinical signs and gross pathology
  • 29.4. Histopathology
  • 29.5. Clinical pathology
  • 29.6. Disease risk factors
  • 29.7. Pathogen isolation and identification
  • 29.8. Molecular diagnostics
  • 29.9. Disease control
  • Chapter 30. Gray crab disease
  • 30.1. Overview
  • 30.2. Etiological agent
  • 30.3. Clinical signs and gross pathology
  • 30.4. Histopathology
  • 30.5. Disease risk factors
  • 30.6. Clinical pathology
  • 30.7. Pathogen isolation and identification
  • 30.8. Molecular diagnostics
  • 30.9. Disease control
  • Chapter 31. Lobster bumper car disease
  • 31.1. Overview
  • 31.2. Etiological agent
  • 31.3. Clinical signs and gross pathology
  • 31.4. Histopathology
  • 31.5. Disease risk factors
  • 31.6. Clinical pathology
  • 31.7. Pathogen isolation and identification
  • 31.8. Molecular and immunological diagnostics
  • 31.9. Disease control
  • Chapter 32. Mud crab Octolasmis spp. infestation
  • 32.1. Overview
  • 32.2. Etiological agent
  • 32.3. Clinical signs and gross pathology
  • 32.4. Histopathology
  • 32.5. Disease risk factors
  • 32.6. Pathogen identification and culture
  • 32.7. Disease control
  • Chapter 33. Shrimp fouling organisms
  • 33.1. Overview
  • 33.2. Etiological agents
  • 33.3. Clinical signs and gross pathology
  • 33.4. Histopathology
  • 33.5. Disease risk factors
  • 33.6. Clinical pathology
  • 33.7. Pathogen isolation and identification
  • 33.8. Disease control
  • Chapter 34. White feces syndrome
  • 34.1. Overview
  • 34.2. Etiological agents
  • 34.3. Clinical signs and gross pathology
  • 34.4. Histopathology
  • 34.5. Disease risk factors
  • 34.6. Pathogen isolation and identification
  • 34.7. Scanning and transmission electron microscopy
  • 34.8. Disease control
  • Chapter 35. Shrimp haplosporidiosis
  • 35.1. Overview
  • 35.2. Etiological agent
  • 35.3. Clinical signs and gross pathology
  • 35.4. Histopathology
  • 35.5. Clinical pathology
  • 35.6. Disease risk factors
  • 35.7. Molecular diagnostics
  • 35.8. Disease control
  • Section V. Fungal diseases
  • Chapter 36. Cotton shrimp
  • 36.1. Overview
  • 36.2. Etiological agents
  • 36.3. Clinical signs and gross pathology
  • 36.4. Histopathology
  • 36.5. Disease risk factors
  • 36.6. Clinical pathology
  • 36.7. Molecular diagnostics
  • 36.8. Disease control
  • Chapter 37. Crab Lagenidium spp. disease
  • 37.1. Overview
  • 37.2. Etiological agents
  • 37.3. Clinical signs, gross and clinical pathology
  • 37.4. Disease risk factors
  • 37.5. Pathogen isolation and identification
  • 37.6. Molecular diagnostics
  • 37.7. Disease control
  • Chapter 38. Crayfish plague
  • 38.1. Overview
  • 38.2. Etiological agent
  • 38.3. Clinical signs and gross pathology
  • 38.4. Histopathology
  • 38.5. Disease risk factors
  • 38.6. Clinical pathology
  • 38.7. Pathogen isolation and identification
  • 38.8. Molecular diagnostics
  • 38.9. Disease control
  • Chapter 39. Crayfish microsporidiosis
  • 39.1. Overview
  • 39.2. Etiological agents
  • 39.3. Clinical signs and gross pathology
  • 39.4. Histopathology
  • 39.5. Disease risk factors
  • 39.6. Clinical pathology
  • 39.7. Molecular diagnostics
  • 39.8. Disease control
  • Chapter 40. Enterocytozoon hepatopenaei microsporidiosis
  • 40.1. Overview
  • 40.2. Etiological agent
  • 40.3. Clinical signs and gross pathology
  • 40.4. Histopathology
  • 40.5. Disease risk factors
  • 40.6. Clinical pathology
  • 40.7. Pathogen isolation and identification
  • 40.8. Immunodiagnostics
  • 40.9. Molecular diagnostics
  • 40.10. Disease control
  • Chapter 41. Lobster haliphthoros disease
  • 41.1. Overview
  • 41.2. Etiological agent
  • 41.3. Clinical signs and gross pathology
  • 41.4. Histopathology
  • 41.5. Disease risk factors
  • 41.6. Clinical pathology
  • 41.7. Pathogen isolation and identification
  • 41.8. Molecular diagnostics
  • 41.9. Disease control
  • Chapter 42. Shrimp fusarium disease
  • 42.1. Overview
  • 42.2. Etiological agents
  • 42.3. Clinical signs and gross pathology
  • 42.4. Histopathology
  • 42.5. Disease risk factors
  • 42.6. Clinical pathology
  • 42.7. Pathogen isolation and identification
  • 42.8. Molecular diagnostics
  • 42.9. Disease control
  • Chapter 43. Shrimp larval mycosis
  • 43.1. Overview
  • 43.2. Etiological agents
  • 43.3. Clinical signs and gross pathology
  • 43.4. Histopathology
  • 43.5. Disease risk factors
  • 43.6. Clinical pathology
  • 43.7. Pathogen isolation and identification
  • 43.8. Molecular diagnostics
  • 43.9. Disease control
  • Section VI. Nutritional diseases
  • Chapter 44. Vitamin deficiencies in shrimp
  • 44.1. Overview
  • 44.2. Etiology/pathogenesis
  • 44.3. Clinical signs and gross pathology
  • 44.4. Histopathology
  • 44.5. Disease risk factors
  • 44.6. Diagnostic tests
  • 44.7. Disease control
  • Chapter 45. Soft shell and blue shell syndrome in shrimp
  • 45.1. Overview
  • 45.2. Etiology-pathogenesis
  • 45.3. Clinical signs and gross pathology
  • 45.4. Histopathology
  • 45.5. Disease risk factors
  • 45.6. Diagnostic tests
  • 45.7. Disease control
  • Chapter 46. Crab larval mortality and nutrition
  • 46.1. Overview
  • 46.2. Algae, artemia, rotifer, and formulated feeds
  • 46.3. Larval development, nutrition, and endocrine regulation
  • Section VII. Environmental diseases
  • Chapter 47. Black gill disease in shrimp
  • 47.1. Overview
  • 47.2. Etiological agents and pathogenesis
  • 47.3. Clinical signs, gross and histopathology
  • 47.4. Disease control
  • Chapter 48. Endocrine disruption in crustacea
  • 48.1. Overview
  • 48.2. Endocrine-disrupting pathogeneses
  • 48.3. Agrichemicals
  • 48.4. Metals
  • 48.5. Industrial organic chemicals, pharmaceuticals, and hormones
  • 48.6. Summary
  • Chapter 49. Pollutant toxicoses—pesticides, heavy metals, industrial organic chemicals in crustacea
  • 49.1. Overview
  • 49.2. Pesticides
  • 49.3. Heavy metals
  • 49.4. Industrial organic chemicals
  • 49.5. Ecological impact in contaminated sites on crustacea
  • Chapter 50. Crustacean shell diseases
  • 50.1. Overview
  • 50.2. Etiological agents and pathogenesis
  • 50.3. Clinical signs and gross pathology
  • 50.4. Histopathology
  • 50.5. Disease risk factors
  • 50.6. Disease control
  • Chapter 51. Lobster epizootic shell disease
  • 51.1. Overview
  • 51.2. Etiological agents and pathogenesis
  • 51.3. Clinical signs and gross pathology
  • 51.4. Histopathology
  • 51.5. Disease risk factors
  • 51.6. Clinical pathology
  • 51.7. Pathogen isolation and identification
  • 51.8. Molecular diagnostics
  • 51.9. Disease control
  • Section VIII. Genetic and neoplastic diseases
  • Chapter 52. Abdominal segment deformity in shrimp
  • 52.1. Overview
  • 52.2. Etiological agent
  • 52.3. Clinical signs and gross pathology
  • 52.4. Histopathology
  • 52.5. Disease risk factors
  • 52.6. Disease control
  • Chapter 53. Inbreeding of shrimp, crab, and lobsters
  • 53.1. Overview
  • 53.2. Measurements of inbreeding
  • 53.3. Health impacts of inbreeding
  • 53.4. Control of inbreeding
  • Chapter 54. Neoplasia in decapod crustacea
  • 54.1. Overview
  • 54.2. Shrimp neoplasia
  • 54.3. Crab neoplasia
  • 54.4. Lobster neoplasia
  • 54.5. Disease risk factors
  • Section IX. Mollusk diseases
  • Chapter 55. Molluscan disease laboratory methods
  • 55.1. Overview
  • 55.2. Necropsy
  • 55.3. Histopathology
  • 55.4. Electron microscopy
  • 55.5. Molecular and immunodiagnostics
  • 55.6. Clinical pathology
  • 55.7. Pathogen isolation and identification
  • 55.8. Assays for specific diseases
  • Chapter 56. Molluscan diseases terminology
  • 56.1. Overview
  • Chapter 57. Molluscan immunology
  • 57.1. Overview
  • 57.2. Shell defenses, nacre formation, and the mantle
  • 57.3. Mucus defenses
  • 57.4. Host–pathogen interaction
  • 57.5. Pathogen recognition and immune signaling
  • 57.6. Antimicrobial peptides, lysozymes, cytokines, antioxidant enzymes, acute phase proteins, and protease inhibitors
  • 57.7. Hemocytes, hematopoiesis, phagocytosis, and diversification of immune receptors in oyster immune priming
  • 57.8. Respiratory burst and nitrogen oxide production
  • 57.9. Encapsulation
  • 57.10. Maternal immune transfer
  • 57.11. Apoptosis and autophagy
  • 57.12. Neuroendocrine-immune regulation
  • 57.13. Prophenoloxidase system
  • 57.14. Immune function genes selection
  • Chapter 58. Molluscan diseases—pearl oyster diseases
  • 58.1. Overview of pearling
  • 58.2. Pearl oyster biology
  • 58.3. Overview of pearl oyster diseases
  • 58.4. Etiological agents
  • 58.5. Gross pathology and clinical signs
  • 58.6. Histopathology
  • 58.7. Immune responses
  • 58.8. Pathogen culture and isolation
  • 58.9. Summary
  • Chapter 59. General pathology and diseases of abalone
  • 59.1. General pathology of abalone
  • 59.2. Physiological changes associated with environmental stressors
  • 59.3. Diseases of abalone—opportunistic infectious diseases
  • 59.4. Abalone diseases recognized as of international significance
  • 59.5. Other pathogens of limited known distribution
  • 59.6. Disseminated parasites with demonstrated pathology
  • 59.7. Minor internal abalone parasites with minimal associated pathology, not common to other commercial mollusks
  • 59.8. Minor parasites similar or common to those of other commercial mollusks
  • 59.9. The pathology of shell invaders
  • Section X. Viral diseases
  • Chapter 60. Abalone herpesvirus
  • 60.1. Overview
  • 60.2. Characterization of the pathogen
  • 60.3. Gross pathology and clinical signs
  • 60.4. Histopathology
  • 60.5. Molecular diagnostics
  • 60.6. Disease control
  • Chapter 61. Diseases of viral origin in clams, mussels, and scallops
  • 61.1. Overview
  • 61.2. Etiological agents
  • 61.3. Clinical signs and gross pathology
  • 61.4. Histopathology
  • 61.5. Disease risk factors
  • 61.6. Clinical pathology
  • 61.7. Pathogen isolation and identification
  • 61.8. Molecular diagnostics
  • 61.9. Immunodiagnostics
  • 61.10. Disease control
  • Chapter 62. Hemocytic infection virus disease (oysters)
  • 62.1. Overview
  • 62.2. Etiological agents
  • 62.3. Clinical signs and gross pathology
  • 62.4. Histopathology
  • 62.5. Disease risk factors
  • 62.6. Disease control
  • Chapter 63. Ostreid herpesvirus disease
  • 63.1. Overview
  • 63.2. Etiological agent
  • 63.3. Clinical signs and gross pathology
  • 63.4. Disease risk factors
  • 63.5. Pathogen isolation and identification
  • 63.6. Disease control
  • 63.7. Conclusion
  • Chapter 64. Oyster velar virus disease
  • 64.1. Overview
  • 64.2. Etiological agent
  • 64.3. Clinical signs
  • 64.4. Histopathology
  • 64.5. Disease risk factors
  • 64.6. Clinical pathology
  • 64.7. Disease control
  • Chapter 65. Viral gametocytic hypertrophy (oysters)
  • 65.1. Overview
  • 65.2. Etiological agents
  • 65.3. Clinical signs and gross pathology
  • 65.4. Histopathology
  • 65.5. Disease risk factors
  • 65.6. Disease control
  • Section XI. Bacterial diseases
  • Chapter 66. Vibriosis in larval scallops
  • 66.1. Overview
  • 66.2. Etiological agents
  • 66.3. Clinical signs
  • 66.4. Histopathology
  • 66.5. Disease risk factors
  • 66.6. Clinical pathology
  • 66.7. Pathogen isolation and identification
  • 66.8. Molecular diagnostics
  • 66.9. Disease control
  • Chapter 67. Nocardiosis in oysters
  • 67.1. Overview
  • 67.2. Etiological agent
  • 67.3. Clinical signs and gross pathology
  • 67.4. Histopathology
  • 67.5. Disease risk factors
  • 67.6. Clinical pathology
  • 67.7. Pathogen isolation and identification
  • 67.8. Molecular diagnostics
  • 67.9. Disease control
  • Chapter 68. Scallop infections by chlamydia-like and rickettsia-like organisms
  • 68.1. Overview
  • 68.2. Etiological agent
  • 68.3. Clinical signs and gross pathology
  • 68.4. Histopathology
  • 68.5. Disease risk factors
  • 68.6. Pathogen isolation and identification
  • 68.7. Immunodiagnostics
  • 68.8. Molecular diagnostics
  • 68.9. Disease control
  • Chapter 69. Vibriosis in green mussels
  • 69.1. Overview
  • 69.2. Etiological agents
  • 69.3. Clinical signs and pathology
  • 69.4. Disease risks factors
  • 69.5. Virulence factors of vibrios
  • 69.6. Disease prevention and control
  • Section XII. Parasitic diseases
  • Chapter 70. Bonamiasis
  • 70.1. Overview
  • 70.2. Etiological agent
  • 70.3. Clinical signs and gross pathology
  • 70.4. Histopathology
  • 70.5. Disease risk factors
  • 70.6. Transmission electron microscopy
  • 70.7. Diagnostic tests
  • 70.8. Molecular diagnostics
  • 70.9. In situ hybridization
  • 70.10. Disease control
  • Chapter 71. Molluscan haplosporidiosis
  • 71.1. Overview
  • 71.2. Etiological agents
  • 71.3. Clinical signs and gross pathology
  • 71.4. Histopathology
  • 71.5. Disease risk factors
  • 71.6. Clinical pathology
  • 71.7. Pathogen isolation and identification
  • 71.8. Molecular diagnostics
  • 71.9. Disease control
  • Chapter 72. Kidney coccidiosis (scallop, abalone, mussels, oysters, and clams)
  • 72.1. Overview
  • 72.2. Etiological agent
  • 72.3. Clinical signs and gross pathology
  • 72.4. Histopathology
  • 72.5. Disease risk factors
  • 72.6. Clinical pathology
  • 72.7. Disease control
  • Chapter 73. Marteiliosis
  • 73.1. Overview
  • 73.2. Etiological agent
  • 73.3. Clinical signs and gross pathology
  • 73.4. Histopathology
  • 73.5. Disease risk factors
  • 73.6. Clinical pathology
  • 73.7. Pathogen isolation and identification
  • 73.8. Molecular diagnostics
  • 73.9. Disease control
  • Chapter 74. Mikrocytos mackini infection
  • 74.1. Overview
  • 74.2. Etiological agent
  • 74.3. Clinical signs and gross pathology
  • 74.4. Histopathology
  • 74.5. Disease risk factors
  • 74.6. Clinical pathology
  • 74.7. Pathogen isolation and identification
  • 74.8. Molecular diagnostics
  • 74.9. Disease control
  • Chapter 75. Nematopsis sp. infections
  • 75.1. Overview
  • 75.2. Etiological agent
  • 75.3. Clinical signs and gross pathology
  • 75.4. Histopathology
  • 75.5. Disease risk factors
  • 75.6. Scanning electron microscopy
  • 75.7. Molecular analysis
  • 75.8. Disease control
  • Chapter 76. Perkinsosis
  • 76.1. Overview
  • 76.2. Etiological agents
  • 76.3. Clinical signs and gross pathology
  • 76.4. Histopathology and host–parasite interactions
  • 76.5. Disease risk factors
  • 76.6. Clinical pathology
  • 76.7. Pathogen isolation and identification
  • 76.8. Immunodiagnostics
  • 76.9. Molecular diagnostics
  • 76.10. Disease control
  • Chapter 77. Shell-boring polychaetes (mudworms) and sponges affecting oysters, scallops, and abalone
  • 77.1. Overview
  • 77.2. Etiological agents
  • 77.3. Clinical signs and gross pathology
  • 77.4. Diagnosis
  • 77.5. Disease risk factors
  • 77.6. Disease treatment and control
  • Section XIII. Fungal and nutritional diseases
  • Chapter 78. Ostracoblabe implexa disease of oysters
  • 78.1. Overview
  • 78.2. Etiological agent
  • 78.3. Clinical signs and gross pathology
  • 78.4. Histopathology
  • 78.5. Disease risk factors
  • 78.6. Clinical pathology
  • 78.7. Pathogen isolation and identification
  • 78.8. Disease control
  • Chapter 79. Sirolpidium zoophthorum larval mycosis
  • 79.1. Overview
  • 79.2. Etiological agent
  • 79.3. Clinical signs
  • 79.4. Disease risk factors
  • 79.5. Clinical pathology
  • 79.6. Pathogen isolation and identification
  • 79.7. Disease control
  • Chapter 80. Microsporidiosis (Steinhausia spp.)
  • 80.1. Overview
  • 80.2. Etiological agent
  • 80.3. Clinical signs and gross pathology
  • 80.4. Histopathology
  • 80.5. Disease risk factors
  • 80.6. Disease control
  • Chapter 81. Hatchery nutritional conditions of mollusks
  • 81.1. Overview
  • 81.2. Clinical signs, gross pathology, and histopathology
  • 81.3. Toxic algae and bacteria ingestion disorders
  • 81.4. Disease risk factors
  • 81.5. Disease control
  • Section XIV. Environmental diseases
  • Chapter 82. Pollutant toxicoses of mollusks
  • 82.1. Overview
  • 82.2. Etiological agents
  • 82.3. Clinical signs and gross, clinical, and histopathology
  • 82.4. Disease risk factors
  • 82.5. Disease control
  • Chapter 83. Endocrine disruption in mollusks
  • 83.1. Overview
  • 83.2. Etiological agents and pathogenesis
  • 83.3. Clinical signs, gross pathology, and histopathology
  • 83.4. Disease risk factors
  • 83.5. Disease control
  • Chapter 84. Ocean acidification
  • 84.1. Overview
  • 84.2. Pathogenesis
  • 84.3. Clinical signs and pathology
  • 84.4. Disease risk factors
  • 84.5. Disease control
  • Section XV. Genetic and neoplastic diseases
  • Chapter 85. Inbreeding, genetic selection, and manipulation in oysters
  • 85.1. Overview
  • 85.2. Breeding lines
  • 85.3. Ploidy manipulation
  • 85.4. Inbreeding depression mechanisms
  • 85.5. Inbreeding depression effects
  • 85.6. Outcomes of genetic selection programs
  • 85.7. Control of inbreeding
  • Chapter 86. Hemocytic neoplasia in mollusks
  • 86.1. Overview
  • 86.2. Etiological agents
  • 86.3. Clinical signs and histopathology
  • 86.4. Clinical pathology
  • 86.5. Disease risk factors
  • 86.6. Disease control
  • 86.7. Future research and conclusion
  • Index

Product details

  • No. of pages: 692
  • Language: English
  • Copyright: © Academic Press 2022
  • Published: August 25, 2022
  • Imprint: Academic Press
  • Paperback ISBN: 9780323954341

About the Editors

Frederick S.B. Kibenge

Dr. Frederick Kibenge is Professor of Virology at the Atlantic Veterinary College, University of Prince Edward Island. He obtained his BVM from Makerere University and his PhD from Murdoch University, and he is the former Chairman of the Department of Pathology and Microbiology at the Atlantic Veterinary College. Dr. Kibenge has more than 30 years of experience investigating animal viruses and the biology of viral pathogens. His research focuses on understanding the mechanisms of virus virulence to improve on methods of virus detection and control.

Affiliations and Expertise

Professor of Virology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PEI, Canada

Bernardo Baldisserotto

Bernardo Baldisserotto is a full professor in the Department of Physiology and Pharmacology at the Federal University of Santa Maria. He has published five books on fish physiology and fish culture, and has organized and participated in numerous other books and journal publications. Dr. Baldisserotto is editor-in-chief for the Physiology and Biochemistry section of Neotropical Ichthyology and associate editor of Fishes and the Journal of the World Aquaculture Society.

Affiliations and Expertise

Full Professor, Department of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil

Roger Sie-Maen Chong

Dr. Roger Sie-Maen CHONG is a veterinary specialist in Australia and the United Kingdom (UK), with expertise in fish and shellfish pathology as applied to the health and biosecurity of aquacultured species. He is officially registered as a specialist by the Queensland Board of Veterinary Surgeons for Veterinary Aquatic Animal Health (Australia) and by the Royal College of Veterinary Surgeons for Fish Health and Production (UK). He is also a certified Fish Pathologist recognized by the Fish Health Section of the American Fisheries Society. Dr. Chong has worked in Hong Kong with the Department of Agriculture, Fisheries & Conservation, in Queensland with the Biosecurity Queensland and is presently a research fish pathologist with the Australian Commonwealth Scientific and Industrial Research Organization (CSIRO).

Affiliations and Expertise

Registered Veterinary Specialist of Fish Health and Production, Royal College of Veterinary Surgeons, UK; Registered Specialist of Veterinary Aquatic Animal Health, Queensland Veterinary Surgeons Board; Australia Veterinary Aquatic Pathologist, Commonwealth Scientific and Industrial Research Organization (CSIRO), Australia

Ratings and Reviews

Write a review

There are currently no reviews for "Aquaculture Pathophysiology"